Alembic Pharmaceuticals Ltd. Investor Presentation

Alembic Pharmaceuticals Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Alembic Pharmaceuticals Ltd.
25 Jan 2017
936.95
0.17%
Announces Q3 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & …
BSE India
Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2016 The Unaudited Standalone results for the Quarter ended December 31, 2016:The Company has posted a net profit of Rs. 1378.30 million for the quarter ended December 31, 2016 as compared to Rs. 2789.20 million for the quarter ended December 31, 2015. Total Income has decreased from Rs. 9096.50 million for the quarter ended December...
pdf
logo
Alembic Pharmaceuticals Ltd.
25 Oct 2016
936.95
0.17%
Announces Q2 Results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & …
BSE India
Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2016The Unaudited Standalone results for the Quarter ended September 30, 2016 The Company has posted a net profit of Rs. 1138.30 million for the quarter ended September 30, 2016 as compared to Rs. 2522.70 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 9319.00 million for the quarter ended September...
pdf
logo
Alembic Pharmaceuticals Ltd.
29 Jul 2016, 01:28PM
936.95
0.17%
Announces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated), Results Press Release & …
BSE India
Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2016:The Unaudited Standalone results for the Quarter ended June 30, 2016The Company has posted a net profit after tax of Rs. 1197.40 million for the quarter ended June 30, 2016 as compared to Rs. 781.50 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 5741.00 million for the quarter ended June 30, 2015 to...
pdf
logo
Alembic Pharmaceuticals Ltd.
27 Apr 2016
936.95
0.17%
Investor Presentation
BSE India
Alembic Pharmaceuticals Ltd has submitted to BSE a copy of Investor Presentation.
pdf
logo
Alembic Pharmaceuticals Ltd.
21 Jan 2016
936.95
0.17%
Announces Q3 results, Result Press Release, Investor Presentation & Limited Review Report for the Quarter ended …
BSE India
Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2015:The Unaudited Standalone results for the Quarter ended December 31, 2015The Company has posted a net profit of Rs. 2801.30 million for the quarter ended December 31, 2015 as compared to Rs. 739.90 million for the quarter ended December 31, 2014. Total Income has increased from Rs. 5021.50 million for the quarter ended December 31,...
pdf